Stimulant Use Disorders: Developing Drugs for Treatment; Draft Guidance for Industry; Availability | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2023-D-1848

Stimulant Use Disorders: Developing Drugs for Treatment; Draft Guidance for Industry; Availability

Documents

Comments

Description

Open

Comment Period OpensOct 5, 2023

Comment Period ClosesDec 5, 2023

Type	Title	Posted	Comments	Status
Other	Stimulant Use Disorders: Developing Drugs for Treatment; Guidance for Industry; Draft Guidance	May 13, 2026	--

Total Comments

CDER

2022-830

Stimulant Use Disorders: Developing Drugs for

Draft Guidance for Industry; Availability

Open